Official Title
An Interventional Study on the Use of Air Cleaners to Mitigate Cardiopulmonary Health Impact of Indoor Exposure to Particles and Phthalates in Healthy Adults: a Randomized Double-blinded Crossover Trial.
Brief Title
The Use of Air Cleaners to Mitigate Cardiopulmonary Health Impact of Indoor Exposure to Particles and Phthalates
Protocol ID
NCT03500614
Lead Sponsor
Peking University
Brief Summary
This study aims to evaluate whether a short-term intervention strategy using air cleaner
reduces indoor exposure to airborne particles (particulate matter with an aerodynamic
diameter ≤2.5μm, PM2.5) and phthalates and improves cardiopulmonary health among Chinese
healthy adults based on a randomized double-blinded crossover trial.
Detailed Description
The randomized double-blind crossover trial includes two cohorts with different
intervention and health examination settings and will be conducted in Beijing, China
between November 2017-May 2018.
The first cohort plans to include 70 healthy college students who live in school
dormitories, which were randomized into two dormitory groups to receive either true or
sham air cleaner treatment for 1 week and then alternate the treatment after a wash out
interval of at least 2 weeks (But in the enrollment, only 57 students were recruited
actually). All participants and research staff are blinded to the group assignment. All
participants are encouraged to stay in the dormitory with windows/doors tightly closed
throughout the 1-week treatment period as far as possible, whereas necessary outdoor
activities such as attending classes and dining in school canteens are allowed. All
interventions will start at noon on Tuesday or Thursday and continue to the next morning
of Tuesday or Thursday to avoid issues related to diurnal variation. Real-time PM2.5
concentrations will be measured using portable monitors and airborne PM2.5 mass samples
will be collected in air filters throughout the treatment period. Air and fine particle
phase phthalates samples will be collected using glass sampling tube filled with XAD2
macroporous resin and PM2.5 air filters respectively during the last day (24 hours) of
the treatment period. Health variables, including blood pressure, lung function,
fractional exhaled nitric oxide (FeNO), will be evaluated and biological samples
including morning urine and fasting blood will be collected immediately after the
completion of each treatment period. Efficacy of air cleaner treatment to reduce indoor
exposure to particles and phthalates and related improvements in cardiopulmonary health
variables will be evaluated using professional statistical methods.
The second cohort plans to include 30 healthy college students who will undergo extended
treatment period covering the start, peak and end phases of smog episodes occurring in
Beijing (To avoid dropout, 32 students were initially recruited). All interventions will
start from the beginning to the end of typical smog episodes. PM2.5 exposure monitoring
as detailed above will be performed throughout the treatment period and repeated health
examinations will be conducted at time points corresponding to the start, peak and end
phases of the smog episodes. Efficacy of air cleaner treatment to reduce indoor exposure
to PM2.5 and related improvements in cardiopulmonary health variables throughout the smog
episodes will be evaluated using professional statistical methods.
Study Period
-
Enrollment Count
57 participants
Eligibility Criteria
Inclusion Criteria:
- Healthy college students aged between 18 and 30 years old;
- Will stay within the central urban area of Beijing over the entire study including
the wash-out period;
- BMI <30 kg/m3.
Exclusion Criteria:
- Current or ever smokers;
- A history of chronic respiratory diseases;
- A history of chronic cardiovascular diseases;
- Acute infections;
- Medication use in recent one month;
- Leave Beijing during the intervention.
Filters
Blood Pressure
Lung Function
Inflammation
Oxidative Stress
NA
COMPLETED
ADULT